Government Reveals Critical Prescription Charge Update After 'Tax on Health' Outcry

NHS prescription charges in England are set to remain frozen for the second consecutive year, as announced by the Chancellor. This decision ensures that patients will continue to pay £9.90 per item to collect their medication from pharmacies throughout the 2025/26 financial year, a rate that was initially frozen in April of the current year to help mitigate the 'cost of living crisis'.
This ongoing freeze extends beyond single prescription items, encompassing pre-payment certificates (PPCs) as well. A three-month PPC will retain its price of £32.05, while the 12-month certificate will remain at £114.50. Furthermore, the cost of the hormone replacement therapy (HRT) certificate has also been frozen. The move is projected to save patients approximately £12 million next year and could potentially save individuals hundreds of pounds, given that the fee for a single prescription typically increases by around 30p annually.
Chancellor Rachel Reeves emphasized the government's commitment, stating, "No one should put their health at risk because they can't afford their medication, and as the cost of living still puts pressure on households I'm extending the cash freeze on prescription charges." She also reiterated the commitment to improving the NHS, noting that waiting lists have decreased by 230,000 over the past year. Reeves plans to outline further "fair choices" in the upcoming Budget to address waiting lists, the cost of living, and national debt.
England remains the only country within the United Kingdom to impose prescription charges, with Scotland, Wales, and Northern Ireland having abolished them over a decade ago. While many patients are exempt from paying prescription fees – including those aged 16 to 18 in full-time education, individuals over 60, and those requiring certain drugs like contraception – campaigners argue that the charge represents an "unfair tax on health."
Pharmacy leaders have largely welcomed the freeze but are urging the government to go further by abolishing the charges entirely. Olivier Picard, chairman of the National Pharmacy Association (NPA), articulated their stance: "Many people choose not to collect some or all their prescription medicines because of cost, with potentially dire health consequences." He added that pharmacists, understanding the vital role of medicines, naturally oppose "arbitrary barriers" to access and view the charge as a "tax that especially hits the working poor." The NPA has consistently advocated for free prescription medicines, aligning England with the rest of the UK. Annually, approximately £600 million in revenue is generated from prescription charges in England, which contributes to the delivery of NHS services.
The impact of prescription charges is particularly felt by older demographics. According to charity Age UK, over one in 10 people aged 65 and above in England take at least eight different prescribed medications each week, a figure that rises to nearly one in four for those over 85. The Chancellor is scheduled to make her comprehensive Budget announcement on November 26.
Recommended Articles
Major Investigation Exposes Systemic Failures, Cover-ups, and Repeating Mistakes In NHS Maternity
A national investigation into England's NHS maternity services, led by Lady Amos, has uncovered deep-rooted issues inclu...
Government Reverses Course! Millions Get Say as Local Elections Delay Scrapped After Intense Pressure

The government has executed a dramatic U-turn on its decision to postpone 30 local elections in May, affecting over 4.5 ...
Alarming Rise: Dementia Deaths Skyrocket, Surpassing Expectations with 70,000 Annual Fatalities

Dementia is increasingly becoming a leading cause of death in England, with new figures revealing 2,500 excess deaths la...
Britain Paralyzed by Arctic Blast: 'Storm Goretti' Unleashes Chaos as Nation Grinds to Halt

The UK is facing its second day of severe winter weather, with widespread school closures and travel chaos reported acro...
UK Gripped by Arctic Blast: Record Cold, Blizzards, and Widespread Travel Chaos Predicted

The UK is facing severe travel disruption and health risks due to an Arctic freeze bringing widespread snow, ice, and pl...
UK Doctors' Strikes Intensify as Mediation Urged, No End in Sight

The Indian SUV market sees compact SUVs leading sales in FY2025, with Tata Punch topping the charts. Maruti Brezza and F...
You may also like...
Guardiola's Peculiar Take: Man City vs. Real Madrid Rematch Deemed 'Bit Weird' by Boss!

Manchester City boss Pep Guardiola finds the repeated Champions League encounter with Real Madrid "a little bit weird," ...
Boxing Shocker: Usyk's WBC Title Defense Set for Ancient Pyramids Against Kickboxer!

Oleksandr Usyk will defend his WBC heavyweight title against kickboxing icon Rico Verhoeven on May 23 at the Pyramids of...
Star-Studded Lineup: Gwyneth Paltrow, Jenna Ortega Join Actor Awards Presenters as Stunt Nominees Revealed

The 32nd Annual Actor Awards, hosted by Kristen Bell and streaming live on Netflix on March 1, is set to honor top talen...
Paramount's Mega-Merger with Warner Bros. Discovery Faces Scrutiny Amidst $2.8 Billion Breakup Fee

Paramount Skydance has won the bid for Warner Bros. Discovery after Netflix withdrew its $83 billion offer, agreeing to ...
Lagos Marathon Buzz: How Power Oil Fuels Community Triumph Over Competition

Power Oil introduced an Exclusive Running Community at the Access Bank Lagos City Marathon, shifting focus from individu...
Amal Umar's Raw Revelation: Star Actress Opens Up on Inner Strength and 'The Herd' Role

Amal Umar discusses her transformative role as Habiba in "The Herd," detailing how the complex character pushed her emot...
DR Congo's Controversial $1.2bn US Health Deal Shakes Up Regional Alliances

The Democratic Republic of Congo and Uganda have embraced a new $1.2 billion US health partnership model, committing to ...
Musk Unleashes Scathing Attack on OpenAI in Deposition: 'Nobody Committed Suicide Because of Grok'

Elon Musk's deposition in his lawsuit against OpenAI reveals sharp criticism of the company's AI safety record, with cla...